clomiphene citrate salt clomiphene citrate salt

structural formula

• numbering system
• physical property data
• toxicological data
• ecological data
• molecular structure data
• computing chemical data
• more
  • properties and stability
  • storage method
  • synthesis method
  • purpose

numbering system

cas number:50-41-9

mdl number:mfcd00058322

einecs number:200-035-3

rtecs number:ye0875000

brn number:none

pubchem number:24892851

physical property data

1. character:white or milky white crystalline powder

2. density (g/ml ,25/4℃): undetermined

3. relative vapor density (g /ml,air= 1): undetermined

4. melting point (ºc):116.5-118°c

5. boiling point (ºc,normal pressure): undetermined

6. boiling point (ºc, 5.2 kpa): undetermined

7. refractive index:undetermined

8. flash point (ºc): undetermined

9. specific optical rotation (º ): undetermined

10. autoignition point or ignition temperature (ºc): undetermined

11. vapor pressure (kpa, 25 ºc): undetermined10 , isotope atomic number: 0

11. determine the number of atomic stereocenters: 0

12. the number of uncertain atomic stereocenters: 0

13. determine the number of stereocenters of chemical bonds: 1

14. uncertain number of chemical bond stereocenters: 0

15. number of covalent bond units: 2

properties and stability

none

storage method

sealed in4℃save in a dry place and away from light.

synthesis method

4-hydroxybenzophenone and diethylaminoethyl chloride hydrochloride the salt is etherified to obtain p-diethylaminooxybenzophenone. after addition, hydrolysis, elimination, and chlorination, chlorostilbene amine is produced.[（911-45-5]), and finally use citric acid to form a salt to obtain the product.

purpose

this product is an anti-estrogen (fertility inducer), used in gynecological diseases such as functional uterine bleeding, polycystic ovaries, menstrual disorders and drug-induced amenorrhea.

amily: 宋体; mso-font-kerning: 0pt”>

purpose

this product is an anti-estrogen (fertility inducer), used in gynecological diseases such as functional uterine bleeding, polycystic ovaries, menstrual disorders and drug-induced amenorrhea.